Literature DB >> 17319871

Non-myopathic cardiac events in two patients treated with trastuzumab.

Rebecca L Olin, Shashank S Desai, Kevin Fox, Rebecca Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17319871     DOI： 10.1111/j.1524-4741.2007.00408.x

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  4 in total

1.  Trastuzumab increases pulmonary vein arrhythmogenesis through modulating pulmonary vein electrical and conduction properties via phosphatidylinositol 3-kinase signaling.

Authors:  Jun-Hei Chang; Chen-Chuan Cheng; Yen-Yu Lu; Yao-Chang Chen; Shih-Ann Chen; Yi-Jen Chen
Journal:  Iran J Basic Med Sci       Date:  2020-07       Impact factor: 2.699

Review 2.  Cardiovascular Toxicity of Molecular Targeted Therapy in Cancer Patients: A Double-Edged Sword.

Authors:  Kuan-Liang Liu; Jen-Shi Chen; Shin-Cheh Chen; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2013-07       Impact factor: 2.672

3.  Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 - a prospective study.

Authors:  Grzegorz Piotrowski; Rafał Gawor; Arkadiusz Stasiak; Zenon Gawor; Piotr Potemski; Maciej Banach
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

4.  Trastuzumab-Induced Cardiomyopathy and Intermittent Left Bundle Branch Block.

Authors:  Hassan Tahir; Nikky Bardia; Kulwant Bath; Yasir Ahmed; Muhammad Rafique; Bassam Omar; Christopher Malozzi
Journal:  Cardiol Res       Date:  2019-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.